BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34895103)

  • 1. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience.
    Zhang XT; Wang X; Cao J; Chen W; Qi KM; Qi N; Liang F; Dong XY; Tang GF; Li DP; Sang W; Li ZY; Cheng H; Xu KL
    Hematology; 2021 Dec; 26(1):1025-1030. PubMed ID: 34895103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Norasetthada L; Wongkhantee S; Chaipokam J; Charoenprasert K; Chuncharunee S; Rojnuckarin P; Sirijerachai C; Wanachiwanawin W; Issaragrisil S;
    Ann Hematol; 2021 Oct; 100(10):2443-2452. PubMed ID: 34269837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin].
    Shao YQ; Li XX; Ge ML; Shi J; Zhang J; Huang JB; Huang ZD; Nie N; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):30-5. PubMed ID: 23597461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
    Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
    Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of porcine ALG compared to rabbit ATG as first-line treatment for children with acquired aplastic anemia.
    Zhu Y; Yang Y; Yang W; Song L; Li Y; Fan H; Li Y; Li J; Ye L; Zhao X; Zhou K; Peng G; Jing L; Zhang L; Zhang F
    Eur J Haematol; 2020 Jun; 104(6):562-570. PubMed ID: 32065456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
    Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
    Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
    Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
    Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
    Scheinberg P; Nunez O; Wu C; Young NS
    Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
    Hwang YY; Chan TSY; Chan FHY; Lau CWP; Luk YY; Lau GWN; Chan KP; Leung KH; Kho B; Lau JSM; Lau CK; Mak V; Yip SF; Lin SY; Sim JPY; Kwong YL
    Ann Hematol; 2022 Jun; 101(6):1163-1172. PubMed ID: 35412083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
    Jalaeikhoo H; Khajeh-Mehrizi A
    PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the prognostic factors of very severe aplastic anemia treated with Chinese Kidney-invigorating drugs in combination with anti-lymphocyte globulin or anti-thymocyte globulin.
    Tang XD; Liu F; Li L; Liu C; Zhang SS; Xiao HY; Zheng CM; Xu S; Ma R
    Chin J Integr Med; 2012 Jan; 18(1):40-5. PubMed ID: 22160947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.